Partner Content Partner Content SMi Group: Exclusive Speaker Interview with Professor Nagy H... RNA Therapeutics
Partner Content Partner Content New Confirmed Delegates & Speakers for RNA Therapeutics RNA Therapeutics
Partner Content Partner Content ProQR Therapeutics: RNA Therapeutics for Patients with Cysti... RNA Therapeutics
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
